Auto-Injectors Market

Market Insights on Auto-Injectors covering sales outlook, demand forecast & up-to-date key trends

Auto-Injectors Market By Product Type (Prefilled Auto-injectors, Fillable auto-injectors), distribution channel (Traditional sales channels, hospital pharmacies, retail pharmacies) & Region - Forecast to 2016- 2026

Request Sample Talk to Analyst

Premium Product Pricing

Pharmaceutical companies hold the dominant position in the auto-injectors market. Major players of auto-injectors market, such as MYLAN N.V., kaléo, Inc., Amgen, Abbott Laboratories, etc., hold over 50% revenue share in the global auto-injectors market. Low competition and complex product development processes have increased the entry barriers for new entrants. High entry barriers for new entrants in auto-injectors market leads to higher product pricing. As a result, auto-injectors available in the global market are sold at premium prices as compared to their alternative -- pre-filled syringes.

Evzio, an antidote for opioid overdoses was approved in U.S in 2014 with list price of US$ 575 for two packs, but has showed a shoot up in price in the last three years. Its list price is currently US$ 4,500, a direct rise of about 680%. Epi-Pen, an epinephrine auto-injectors indicated to treat allergic reaction of Mylan Pharmaceuticals, showed a price hike from $100 in 2008 to about $500 in 2016, an increase on 400%.

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

Innovations in Materials and Drug Delivery Techniques

Innovations in materials and device functions of auto-injectors are the prime factors driving the growth of the auto-injectors market. In September 2015, Bayer HealthCare launched Betaconnect- an electronic auto-injectors which is used for the treatment of relapsing-remitting multiple sclerosis (RRMS).

Auto-Injectors Market Download Report Brochure

This auto-injectors offers complete drug dosage for improved compliance and potentially reduces the overall cost. The SHL Group offers a variety of auto-injectors that can accommodate changes in injection needs, such as larger volumes, high viscosity and others. Auto-injectors manufacturers are focusing on improving the functionality of auto-injectors to improve disease management and treatment.

Increased Development and Use of Biologics / Biosimilars

Majority pharmaceutical companies are shifting from small molecules to biologics and vaccines, driven by increased efficacy and immunogenic of large molecules. The growth of biologics is increasing and this growth is playing a major role in defining company pipelines, acquisition strategies as well as the entry of biologics in established markets of the U.S and Europe.

According to the World Health Organization, 5% of the population suffers from autoimmune diseases. Development of new drug categories may offer new knowledge and new therapeutic agents to cure diseases. About 2/3 of the new drugs to be launched in the coming years will be biologic and sustained release drugs and will push the growth of the auto-injectors in near future.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Preferred Choice by Patients in Self-Injection

Auto-injectors are preferred over conventional devices as they facilitate improved drug delivery and new formulations and thus, are increasing the demand for injectable devices. Auto-injectors enhance and improve efficiency in terms of drug delivery as they are more convenient to use.

The demand for auto-injectors devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are expected to make auto-injectors more user friendly and convenient to use. This is motivating patients to adopt this technology for chronic illnesses.

Streamline Regulatory Guidelines

Rising healthcare expenditure will provide significant opportunities to hospitals and auto-injectors manufacturers to adopt new advanced technologies for device development and commercialization. Previously auto-injectors manufacturers relied on the U.S Food and Drug Administration (FDA) 2009 draft guidance for Industry and current Good Manufacturing Practices for combination production. In January 2013, FDA streamlined the cGMP for combination products.

In the US and EU, the auto-injectors are classified under combination products. Combination products are separately regulated under different authorities for biologics, devices and drugs
Auto-injectors are considered single-entity combination products (drug/device and biologic/device) and should retain their regulatory status before and after they are combined

Manufacturers should understand regulations and should be technologically advanced with device design innovation to establish market competitiveness.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Sign-Up

Shifting Production Base to Emerging Economies

Due to availability of well-developed manufacturing infrastructure and low cost labor, multi-national companies are shifting their focus towards emerging economies, such as the Asia Pacific region. Pharmaceutical companies have their manufacturing plants in Asian countries due to easy availability of skilled labor and low cost of raw materials. The strategy used by companies in these countries includes increasing revenue and at the same time, expanding business geographically by marketing products in.

Also, auto-injectors companies are entering into collaborations with other companies to manufacture more advanced and innovative products by sharing their organic resource. In September 2016, Aptar Pharma formed an agreement with Becton, Dickinson & Co. to develop auto-injectors devices to be used safely and conveniently by patients. The two-step auto-injectors will be exclusively sold by Becton, Dickinson & Co. In December 2016, SMC Ltd. acquired Oval Medical Technologies Ltd., developing next generation auto-injectors to enhance its product portfolio and to expand drug delivery capabilities.

For more such actionable insights on the potential of auto-injectors market, request a free sample copy.

Competitive Landscape

The competition section of the auto-injectors market features profiles of key players operating in the industry based on their auto-injectors market shares, product offerings, differential channel strategies, marketing initiatives, product reach and company dashboard. Some of the key players featured in the auto-injectors market report include Sanofi, Pfizer, Inc., Becton, Dickinson and Company, Mylan N.V., Novartis AG, Janssen Global Services, LLC, Antares Pharma, Amgen Inc. Bayer AG, & Eli Lilly and Company.

Key players are focused on portable and user-friendly auto-injectors to maintain and increase their customer base. Companies, such as Mylan N.V., Eli Lilly and Company and Bayer AG, are more focused on user-friendly auto-injectors to maintain their brand equity. New entrants are more focused on tapping the emerging markets by introducing cost effective auto-injectors devices.

Some of the companies, such as Mylan N.V, Teva pharmaceuticals, etc., are introducing generic versions of cost-effective auto-injectors devices and are targeting emerging countries, such as regions of Asia-Pacific, Middle East and others, to sustain and grow in the global Auto-Injectors Market

The key manufacturers of auto-injectors are focusing on novel marketing strategies to increase their product reach. Companies are conducting awareness campaigns to increase their product usage. Price reduction by branded auto-injectors is leading to head-to-head competition in the market. These companies are rebranding their auto-injectors products with lucrative discounts. Conventional distribution channels, such as retail pharmacies, drug stores, etc. would be the key target channels for product distribution.

Definition

Auto-injectors devices are new injectable with a user-centric design approach that automatically inject a needle and perform the surgical procedure, thereby reducing dependence on healthcare professionals. These are specialized instruments that can be used to avoid needle stick injury and reduce needle phobia among patients. These are revolutionary instruments which have been invented to ensure complete dosage with painless drug delivery.

About the Report

FMI conducted a research study on auto-injectors market for the forecast period 2016 to 2026. The report offers a comprehensive evaluation of the business opportunities prevailing in the auto-injectors market along with insights on the consumption trend, dynamics, incidence, patient awareness level, pricing analysis and market competition. The report elaborates on the macroeconomic factors influencing the dynamics of auto-injectors market and its futuristic potential.

Additional Questions Answered

Some of the additional questions addressed in this report on auto-injectors market are-

What is the revenue potential of generic auto-injectors across regions of North America and Europe?
Who are the key competitors and what are their portfolios in auto-injectors market?
What is the price point for generic auto-injectors manufacturers in developed countries?
How interventions from regulatory authorities and insurance service providers are shaping Auto-injectors market growth?

For answers to all possible questions required for gauging performance of auto-injectors market, get in touch with our expert analyst.

Research Methodology

FMI has analyzed the market size of Auto-injectors market using the triangulation methodology. We tracked the revenue of key players operating in this segment. Key Players have been segmented at a Tier-level with respect to their revenues, product portfolio and geographical presence.

This process involved analysis of various company investors’ presentations, SEC filings, annual reports, earning call transcripts, 10k reports and press releases. This task was done to fetch substantial information about the key players, their respective revenues and estimate their respective auto-injectors market share.

The forecast for auto-injectors was conducted based on several macro factors, such as per capita healthcare spending, per capita pharmaceutical spending and availability of reimbursements, patient awareness and other macro factors associated with the healthcare industry. In addition, we have considered the following assumptions during the market forecasting:

Growth in number of patients using auto-injectors and treatment seeking rate
Change in price/ per patient spending on drugs
Adoption curve for available treatment
Impact of launch of new products
Trends pertaining to price sensitivity, patient preference, prescription pattern and pipeline development

Key Segment

based on product type

Prefilled Auto-injectors
Fillable auto-injectors

based on distribution channel

Traditional sales channels
hospital pharmacies
retail pharmacies

based on regions

North America
Latin America
Europe
Asia Pacific Excluding Japan
Japan
MEA

Table of Content

1. Executive Summary

2. Market Introduction

2.1. Auto Injectors Market Definition

2.2. Auto Injectors Market Taxonomy

3. Auto Injectors Market Analysis Scenario

3.1. Market Size (US$ Mn) and Forecast

3.1.1. Market Size and Y-o-Y Growth

3.1.2. Absolute $ Opportunity

4. Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Trends

4.6. Forecast Factors - Relevance and Impact

4.7. PEST Analysis

4.8. Regulations of Auto Injectors - U.S.

5. Global Auto Injectors Market Analysis and Forecast, By Product Type

5.1. Introduction

5.1.1. Basis Point Share (BPS) Analysis By Product Type

5.1.2. Y-o-Y Growth Projections By Product Type

5.2. Market Size (US$ Mn) Forecast By Product Type

5.2.1. Prefilled Auto Injectors

5.2.2. Fillable Auto Injectors

5.3. Market Attractiveness Analysis By Product Type

6. Global Auto Injectors Market Analysis and Forecast, By Therapeutic Area

6.1. Introduction

6.1.1. Basis Point Share (BPS) Analysis By Therapeutic Area

6.1.2. Y-o-Y Growth Projections By Therapeutic Area

6.2. Market Size (US$ Mn) Forecast By Therapeutic Area

6.2.1. Anaphylaxis

6.2.2. Multiple Sclerosis

6.2.3. Rheumatoid Arthritis

6.2.4. Others

6.3. Market Attractiveness Analysis By Therapeutic Area

7. Global Auto Injectors Market Analysis and Forecast, By Distribution Channel

7.1. Introduction

7.1.1. Basis Point Share (BPS) Analysis By Distribution Channel

7.1.2. Y-o-Y Growth Projections By Distribution Channel

7.2. Market Size (US$ Mn) Forecast By Distribution Channel

7.2.1. Hospital Pharmacies

7.2.2. Retail Pharmacies

7.2.3. Online Pharmacies

7.2.4. Drug Stores

7.3. Market Attractiveness Analysis By Distribution Channel

8. Global Auto Injectors Market Analysis and Forecast, By Region

8.1. Introduction

8.1.1. Basis Point Share (BPS) Analysis By Region

8.1.2. Y-o-Y Growth Projections By Region

8.2. Market Size (US$ Mn) Forecast By Region

8.2.1. North America

8.2.2. Latin America

8.2.3. Western Europe

8.2.4. Eastern Europe

8.2.5. Asia Pacific Excl. Japan (APEJ)

8.2.6. Japan

8.2.7. Middle East and Africa (MEA)

8.3. Market Attractiveness Analysis By Region

9. North America Auto Injectors Market Analysis and Forecast

9.1. Introduction

9.1.1. Basis Point Share (BPS) Analysis By Country

9.1.2. Y-o-Y Growth Projections By Country

9.2. Market Size (US$ Mn) Forecast By Country

9.2.1. S.

9.2.2. Canada

9.3. Market Size (US$ Mn) Forecast By Product Type

9.3.1. Prefilled Auto Injectors

9.3.2. Fillable Auto Injectors

9.4. Market Size (US$ Mn) Forecast By Therapeutic Area

9.4.1. Anaphylaxis

9.4.2. Multiple Sclerosis

9.4.3. Rheumatoid Arthritis

9.4.4. Others

9.5. Market Size (US$ Mn) Forecast By Distribution Channel

9.5.1. Hospital Pharmacies

9.5.2. Retail Pharmacies

9.5.3. Online Pharmacies

9.5.4. Drug Stores

9.6. Market Attractiveness Analysis

9.6.1. By Country

9.6.2. By Product Type

9.6.3. By Therapeutic Area

9.6.4. By Distribution Channel

10. Latin America Auto Injectors Market Analysis and Forecast

10.1. Introduction

10.1.1. Basis Point Share (BPS) Analysis By Country

10.1.2. Y-o-Y Growth Projections By Country

10.2. Market Size (US$ Mn) Forecast By Country

10.2.1. Brazil

10.2.2. Mexico

10.2.3. Rest of Latin America

10.3. Market Size (US$ Mn) Forecast By Product Type

10.3.1. Prefilled Auto Injectors

10.3.2. Fillable Auto Injectors

10.4. Market Size (US$ Mn) Forecast By Therapeutic Area

10.4.1. Anaphylaxis

10.4.2. Multiple Sclerosis

10.4.3. Rheumatoid Arthritis

10.4.4. Others

10.5. Market Size (US$ Mn) Forecast By Distribution Channel

10.5.1. Hospital Pharmacies

10.5.2. Retail Pharmacies

10.5.3. Online Pharmacies

10.5.4. Drug Stores

10.6. Market Attractiveness Analysis

10.6.1. By Country

10.6.2. By Product Type

10.6.3. By Therapeutic Area

10.6.4. By Distribution Channel

11. Western Europe Auto Injectors Market Analysis and Forecast

11.1. Introduction

11.1.1. Basis Point Share (BPS) Analysis By Country / Region

11.1.2. Y-o-Y Growth Projections By Country

11.2. Market Size (US$ Mn) Forecast By Country / Region

11.2.1. Germany

11.2.2. France

11.2.3. Italy

11.2.4. Spain

11.2.5. K.

11.2.6. BENELUX

11.2.7. Rest of Western Europe

11.3. Market Size (US$ Mn) Forecast By Product Type

11.3.1. Prefilled Auto Injectors

11.3.2. Fillable Auto Injectors

11.4. Market Size (US$ Mn) Forecast By Therapeutic Area

11.4.1. Anaphylaxis

11.4.2. Multiple Sclerosis

11.4.3. Rheumatoid Arthritis

11.4.4. Others

11.5. Market Size (US$ Mn) Forecast By Distribution Channel

11.5.1. Hospital Pharmacies

11.5.2. Retail Pharmacies

11.5.3. Online Pharmacies

11.5.4. Drug Stores

11.6. Market Attractiveness Analysis

11.6.1. By Country

11.6.2. By Product Type

11.6.3. By Therapeutic Area

11.6.4. By Distribution Channel

12. Eastern Europe Auto Injectors Market Analysis and Forecast

12.1. Introduction

12.1.1. Basis Point Share (BPS) Analysis By Country

12.1.2. Y-o-Y Growth Projections By Country

12.2. Market Size (US$ Mn) Forecast By Country

12.2.1. Russia

12.2.2. Poland

12.2.3. Rest of Eastern Europe

12.3. Market Size (US$ Mn) Forecast By Product Type

12.3.1. Prefilled Auto Injectors

12.3.2. Fillable Auto Injectors

12.4. Market Size (US$ Mn) Forecast By Therapeutic Area

12.4.1. Anaphylaxis

12.4.2. Multiple Sclerosis

12.4.3. Rheumatoid Arthritis

12.4.4. Others

12.5. Market Size (US$ Mn) Forecast By Distribution Channel

12.5.1. Hospital Pharmacies

12.5.2. Retail Pharmacies

12.5.3. Online Pharmacies

12.5.4. Drug Stores

12.6. Market Attractiveness Analysis

12.6.1. By Country

12.6.2. By Product Type

12.6.3. By Therapeutic Area

12.6.4. By Distribution Channel

13. Asia Pacific Excl. Japan (APEJ) Auto Injectors Market Analysis and Forecast

13.1. Introduction

13.1.1. Basis Point Share (BPS) Analysis By Country / Region

13.1.2. Y-o-Y Growth Projections By Country / Region

13.2. Market Size (US$ Mn) Forecast By Country / Region

13.2.1. China

13.2.2. India

13.2.3. ASEAN

13.2.4. Australia and New Zealand

13.2.5. Rest of APEJ

13.3. Market Size (US$ Mn) Forecast By Product Type

13.3.1. Prefilled Auto Injectors

13.3.2. Fillable Auto Injectors

13.4. Market Size (US$ Mn) Forecast By Therapeutic Area

13.4.1. Anaphylaxis

13.4.2. Multiple Sclerosis

13.4.3. Rheumatoid Arthritis

13.4.4. Others

13.5. Market Size (US$ Mn) Forecast By Distribution Channel

13.5.1. Hospital Pharmacies

13.5.2. Retail Pharmacies

13.5.3. Online Pharmacies

13.5.4. Drug Stores

13.6. Market Attractiveness Analysis

13.6.1. By Country

13.6.2. By Product Type

13.6.3. By Therapeutic Area

13.6.4. By Distribution Channel

14. Japan Auto Injectors Market Analysis and Forecast

14.1. Market Size (US$ Mn) Forecast By Product Type

14.1.1. Prefilled Auto Injectors

14.1.2. Fillable Auto Injectors

14.2. Market Size (US$ Mn) Forecast By Therapeutic Area

14.2.1. Anaphylaxis

14.2.2. Multiple Sclerosis

14.2.3. Rheumatoid Arthritis

14.2.4. Others

14.3. Market Size (US$ Mn) Forecast By Distribution Channel

14.3.1. Hospital Pharmacies

14.3.2. Retail Pharmacies

14.3.3. Online Pharmacies

14.3.4. Drug Stores

14.4. Market Attractiveness Analysis

14.4.1. By Product Type

14.4.2. By Therapeutic Area

14.4.3. By Distribution Channel

15. Middle East and Africa (MEA) Auto Injectors Market Analysis and Forecast

15.1. Introduction

15.1.1. Basis Point Share (BPS) Analysis By Country

15.1.2. Y-o-Y Growth Projections By Country

15.2. Market Size (US$ Mn) Forecast By Country

15.2.1. GCC

15.2.2. South Africa

15.2.3. Rest of MEA

15.3. Market Size (US$ Mn) Forecast By Product Type

15.3.1. Prefilled Auto Injectors

15.3.2. Fillable Auto Injectors

15.4. Market Size (US$ Mn) Forecast By Therapeutic Area

15.4.1. Anaphylaxis

15.4.2. Multiple Sclerosis

15.4.3. Rheumatoid Arthritis

15.4.4. Others

15.5. Market Size (US$ Mn) Forecast By Distribution Channel

15.5.1. Hospital Pharmacies

15.5.2. Retail Pharmacies

15.5.3. Online Pharmacies

15.5.4. Drug Stores

15.6. Market Attractiveness Analysis

15.6.1. By Country

15.6.2. By Product Type

15.6.3. By Therapeutic Area

15.6.4. By Distribution Channel

16. Competition Landscape

16.1. Competition Dashboard

16.2. Global Company Share Analysis (2015)

16.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

16.4. Global Players

16.4.1. Becton, Dickinson and Company

16.4.2. Sanofi

16.4.3. Pfizer, Inc.

16.4.4. Mylan N.V.

16.4.5. Novartis AG

16.4.6. Bayer AG

16.4.7. Janssen Global Services, LLC

16.4.8. Antares Pharma, Inc.

16.4.9. Amgen Inc.

16.4.10. Eli Lilly and Company

17. Assumptions and Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

List of Tables

Global Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Product, 2016 – 2026
Global Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Indication, 2016 – 2026
Global Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2016 – 2026
Global Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Region, 2016 – 2026
North America Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Country, 2016 – 2026
North America Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Product, 2016 – 2026
North America Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Indication, 2016 – 2026
North America Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2016 –
Latin America Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Country, 2016 – 2026
Latin America Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Product, 2016 – 2026
Latin America Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Indication, 2016 – 2026
Latin America Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2016
Western Europe Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Country, 2016 – 2026
Western Europe Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Product, 2016 – 2026
Western Europe Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Indication, 2016 – 2026
Western Europe Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2016
Eastern Europe Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Country, 2016 – 2026
Eastern Europe Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Product, 2016 – 2026
Eastern Europe Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Indication, 2016 – 2026
Eastern Europe Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2016
APEJ Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Country, 2016 – 2026
APEJ Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Product, 2016 – 2026
APEJ Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Indication, 2016 – 2026
APEJ Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2016 – 2026
Japan Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Product, 2016 – 2026
Japan Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Indication, 2016 – 2026
Japan Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2016 – 2026
MEA Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Country, 2016 – 2026
MEA Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Product, 2016 – 2026
MEA Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Indication, 2016 – 2026
MEA Auto-Injectors Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2016 – 2026

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Global Auto-Injectors Market Share Analysis (%) By Product Type, 2016 & 2026
Global Auto-Injectors Market Y-o-Y Growth (%) By Product Type, 2015–2026
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Prefilled Auto-injectors
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Fillable Auto-injectors Segment, 2016 – 2026
Global Auto-Injectors Market Attractiveness Analysis By Product, 2016–2026
Global Auto-Injectors Market Share Analysis (%) By Indication, 2016 & 2026
Global Auto-Injectors Market Y-o-Y Growth (%) By Indication, 2015–2026
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Anaphylaxis
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Multiple Sclerosis Segment, 2016 – 2026
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Rheumatoid Arthritis
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016 – 2026
Global Auto-Injectors Market Attractiveness Analysis By Indication, 2016–2026
Global Auto-Injectors Market Share Analysis (%) By Distribution Channel, 2016 & 2026
Global Auto-Injectors Market Y-o-Y Growth (%) By Distribution Channel, 2015–2026
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Hospital Pharmacies
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Retail Pharmacies Segment, 2016 – 2026
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Online Pharmacies
Global Auto-Injectors Market Absolute $ Opportunity (US$ Mn) By Drug Stores Segment, 2016 – 2026
Global Auto-Injectors Market Attractiveness Analysis By Distribution Channel, 2016–2026
Global Auto-Injectors Market Share Analysis (%) By Region, 2016 & 2026
Global Auto-Injectors Market Y-o-Y Growth (%) By Region, 2015–2026
North America Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Latin America Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Western Europe Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Eastern Europe Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
APEJ Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Japan Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
MEA Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Global Auto-Injectors Market Attractiveness Analysis By Region, 2016–2026
North America Auto-Injectors Market Share Analysis (%) By Country, 2016, 2026
North America Auto-Injectors Market Y-o-Y Growth (%) By Country, 2015–2026
U.S. Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Canada Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
North America Auto-Injectors Market Attractiveness Analysis By Country, 2016–2026
North America Auto-Injectors Market Attractiveness Analysis By Product, 2016–2026
North America Auto-Injectors Market Attractiveness Analysis By Indication, 2016–2026
North America Auto-Injectors Market Attractiveness Analysis By Distribution Channel, 2016–2026
Latin America Auto-Injectors Market Share Analysis (%) By Country, 2016, 2026
Latin America Auto-Injectors Market Y-o-Y Growth (%) By Country, 2015–2026
Brazil Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Mexico Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Rest of Latin America Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Latin America Auto-Injectors Market Attractiveness Analysis By Country, 2016–2026
Latin America Auto-Injectors Market Attractiveness Analysis By Product, 2016–2026
Latin America Auto-Injectors Market Attractiveness Analysis By Indication, 2016–2026
Latin America Auto-Injectors Market Attractiveness Analysis By Distribution Channel, 2016–2026
Western Europe Auto-Injectors Market Share Analysis (%) By country, 2016 & 2026
Western Europe Auto-Injectors Market Y-o-Y Growth (%) By Country, 2015–2026
Germany Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
France Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Italy Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Spain Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
U.K. Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
BENELUX Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Rest of Western Europe Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Western Europe Auto-Injectors Market Attractiveness Analysis By Country, 2016–2026
Western Europe Auto-Injectors Market Attractiveness Analysis By Product, 2016–2026
Western Europe Auto-Injectors Market Attractiveness Analysis By Indication, 2016–2026
Western Europe Auto-Injectors Market Attractiveness Analysis By Distribution Channel, 2016–2026
Eastern Europe Auto-Injectors Market Share Analysis (%) By Country, 2016 & 2026
Eastern Europe Auto-Injectors Market Y-o-Y Growth (%) By Country, 2015–2026
Russia Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Poland Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Rest of Eastern Europe Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Eastern Europe Auto-Injectors Market Attractiveness Analysis By Country, 2016–2026
Eastern Europe Auto-Injectors Market Attractiveness Analysis By Product, 2016–2026
Eastern Europe Auto-Injectors Market Attractiveness Analysis By Indication, 2016–2026
Eastern Europe Auto-Injectors Market Attractiveness Analysis By Distribution Channel, 2016–2026
APEJ Auto-Injectors Market Share Analysis (%) By country, 2016 & 2026
APEJ Auto-Injectors Market Y-o-Y Growth (%) By Country, 2015–2026
China Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
India Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
ASEAN Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Australia & New Zealand Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Rest of APEJ Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
APEJ Auto-Injectors Market Attractiveness Analysis By Country, 2016–2026
APEJ Auto-Injectors Market Attractiveness Analysis By Product, 2016–2026
APEJ Auto-Injectors Market Attractiveness Analysis By Indication, 2016–2026
APEJ Auto-Injectors Market Attractiveness Analysis By Distribution Channel, 2016–2026
Japan Auto-Injectors Market Attractiveness Analysis By Product, 2016–2026
Japan Auto-Injectors Market Attractiveness Analysis By Indication, 2016–2026
Japan Auto-Injectors Market Attractiveness Analysis By Distribution Channel, 2016–2026
MEA Auto-Injectors Market Share Analysis (%) By Country, 2016, 2026
MEA Auto-Injectors Market Y-o-Y Growth (%) By Country, 2015–2026
GCC Countries Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
South Africa Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
Rest of MEA Auto-Injectors Market Absolute $ Opportunity (US$ Mn), 2016 – 2026
MEA Auto-Injectors Market Attractiveness Analysis By Country, 2016–2026
MEA Auto-Injectors Market Attractiveness Analysis By Product, 2016–2026
MEA Auto-Injectors Market Attractiveness Analysis By Indication, 2016–2026
MEA Auto-Injectors Market Attractiveness Analysis By Distribution Channel, 2016–2026
Global Auto-Injectors Market Share Analysis, 2015